Some studies have shown that overexpression of BCL-2 or BCL-xL is commonly observed in acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) [71, 72]. Here, BCL2L1 is linked to B-cell chronic lymphocytic leukemia.